Price of 17 items cut 30% during Type C PVA negotiations
By Lee, Tak-Sun | translator Kang, Shin-Kook
24.08.28 05:54:16
°¡³ª´Ù¶ó
0
36% increase in reductions for drugs with claims over KRW 30 billion annually
64 items were excluded from negotiations due to revised guidelines
The National Health Insurance Service (NHIS) has announced that it has achieved health insurance financial savings of KRW 52.1 billion (USD 52.1 million) through ¡®Type C¡¯ Price-Volume Agreement (PVA) negotiations this year.
This is an 85.5% increase from the KRW 28.1 billion in the previous year. In particular, the revision of the detailed operating guidelines contributed to a 36% increase in the price reduction rate of high-cost drugs that billed more than KRW 30 billion per year compared to before the guidelines were revised.
The National Health Insurance Service (President: Ki-suck Jung, NHIS) announced that it has completed negotiations for 63 product groups (207 items) subj
Lee, Tak-Sun(hooggasi2@dailypharm.com)
If you want to see the full article, please JOIN US (click)